B. Singer

4.7k total citations
122 papers, 3.7k citations indexed

About

B. Singer is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Neurology. According to data from OpenAlex, B. Singer has authored 122 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Molecular Biology, 42 papers in Pathology and Forensic Medicine and 14 papers in Neurology. Recurrent topics in B. Singer's work include Multiple Sclerosis Research Studies (42 papers), DNA and Nucleic Acid Chemistry (36 papers) and DNA Repair Mechanisms (22 papers). B. Singer is often cited by papers focused on Multiple Sclerosis Research Studies (42 papers), DNA and Nucleic Acid Chemistry (36 papers) and DNA Repair Mechanisms (22 papers). B. Singer collaborates with scholars based in United States, Germany and Canada. B. Singer's co-authors include H. Fraenkel‐Conrat, J. T. Kuśmierek, Bo Hang, Manjit Dosanjh, Lin Sun, Ahmed Chenna, Howard Riezman, Thomas P. Brent, Ferman A. Chavez and Sylvia J. Spengler and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

B. Singer

122 papers receiving 3.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. Singer United States 34 2.6k 751 542 383 318 122 3.7k
Yoshiyuki Kuchino Japan 39 4.8k 1.9× 816 1.1× 357 0.7× 786 2.1× 232 0.7× 132 6.2k
Carl W. Porter United States 52 6.3k 2.4× 295 0.4× 315 0.6× 479 1.3× 387 1.2× 166 7.7k
James E. Thompson United States 34 2.2k 0.8× 658 0.9× 180 0.3× 617 1.6× 252 0.8× 148 4.6k
Masaru Takeshita Japan 27 3.8k 1.4× 1.0k 1.4× 270 0.5× 768 2.0× 403 1.3× 71 5.0k
Michael A. Sirover United States 33 3.3k 1.2× 732 1.0× 135 0.2× 348 0.9× 92 0.3× 69 4.5k
Maria C. Shoshan Sweden 36 2.4k 0.9× 672 0.9× 300 0.6× 937 2.4× 189 0.6× 77 4.0k
Dianne L. Newton United States 35 3.1k 1.2× 466 0.6× 165 0.3× 681 1.8× 301 0.9× 87 4.6k
Albert H. Gennip Netherlands 39 4.8k 1.8× 356 0.5× 268 0.5× 1.7k 4.5× 242 0.8× 135 6.7k
Hans Jörnvall Sweden 29 2.9k 1.1× 258 0.3× 443 0.8× 331 0.9× 109 0.3× 97 4.6k
Paul W. Doetsch United States 37 3.2k 1.2× 783 1.0× 250 0.5× 514 1.3× 176 0.6× 73 4.0k

Countries citing papers authored by B. Singer

Since Specialization
Citations

This map shows the geographic impact of B. Singer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Singer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Singer more than expected).

Fields of papers citing papers by B. Singer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Singer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Singer. The network helps show where B. Singer may publish in the future.

Co-authorship network of co-authors of B. Singer

This figure shows the co-authorship network connecting the top 25 collaborators of B. Singer. A scholar is included among the top collaborators of B. Singer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Singer. B. Singer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Singer, B., et al.. (2024). Patient and Physician Perspectives of Treatment Burden in Multiple Sclerosis. Neurology and Therapy. 13(6). 1507–1525. 1 indexed citations
2.
Singer, B., Sibyl Wray, Mark Gudesblatt, et al.. (2024). Lymphopenia is Not the Primary Therapeutic Mechanism of Diroximel Fumarate in Relapsing–Remitting Multiple Sclerosis: Subgroup Analyses of the EVOLVE-MS-1 Study. Neurology and Therapy. 13(4). 1273–1285. 2 indexed citations
3.
Freedman, Mark S., Patricia K. Coyle, Kerstin Hellwig, et al.. (2024). Twenty Years of Subcutaneous Interferon-Beta-1a for Multiple Sclerosis: Contemporary Perspectives. Neurology and Therapy. 13(2). 283–322. 4 indexed citations
4.
Giovannoni, Gavin, et al.. (2021). Durability of no evidence of disease activity-3 (NEDA-3) in patients receiving cladribine tablets: The CLARITY extension study. Multiple Sclerosis Journal. 28(8). 1219–1228. 23 indexed citations
5.
6.
Freedman, Mark S., Staley A. Brod, B. Singer, et al.. (2019). Clinical and MRI efficacy of sc IFN β-1a tiw in patients with relapsing MS appearing to transition to secondary progressive MS: post hoc analyses of PRISMS and SPECTRIMS. Journal of Neurology. 267(1). 64–75. 4 indexed citations
7.
Wijmeersch, Bart Van, B. Singer, Aaron Boster, et al.. (2019). Efficacy of alemtuzumab over 6 years in relapsing–remitting multiple sclerosis patients who relapsed between courses 1 and 2: Post hoc analysis of the CARE-MS studies. Multiple Sclerosis Journal. 26(13). 1719–1728. 16 indexed citations
8.
9.
10.
11.
Krieger, Stephen, B. Singer, Mark S. Freedman, et al.. (2016). Treatment-Naive Patients with Highly Active RRMS Demonstrated Durable Efficacy with Alemtuzumab over 5 Years (S51.003). Neurology. 86(16_supplement). 7 indexed citations
12.
Singer, B., Edward Fox, Stephen Krieger, et al.. (2015). Durable Efficacy of Alemtuzumab in Patients With Highly Active Relapsing-Remitting Multiple Sclerosis Who Relapsed on a Prior Therapy (P7.269). Neurology. 84(14_supplement). 1 indexed citations
13.
Tullman, Mark, et al.. (2015). A Pilot Study of Dalfampridine for Improving Upper Extremity Function in Multiple Sclerosis Patients (P1.124). Neurology. 84(14_supplement). 1 indexed citations
14.
Singer, B., Cristoforo Comi, Aaron Miller, et al.. (2014). Teriflunomide Treatment Is Not Associated With Increased Risk of Infections: Pooled Data From the Teriflunomide Development Program (P2.194). Neurology. 82(10_supplement). 1 indexed citations
15.
Singer, B., et al.. (2011). Oral fingolimod for the treatment of patients with relapsing forms of multiple sclerosis. International Journal of Clinical Practice. 65(8). 887–895. 23 indexed citations
16.
Lau, Albert Y., Brian Glassner, Leona D. Samson, et al.. (2001). Molecular basis for discriminating between normal and damaged bases by the human alkyladenine glycosylase, AAG. 14(3). 142–147. 8 indexed citations
17.
18.
Singer, B. & Helmut Bartsch. (1986). The Role of cyclic nucleic acid adducts in carcinogenesis and mutagenesis : proceedings of a meeting organized by the IARC and co-sponsored by the US National Cancer Institute, and the Lawrence Berkeley Laboratory at the University of California, held in Lyon, 17-19 September 1984. 8 indexed citations
19.
Singer, B., et al.. (1976). O2 ‐alkylcytidine ‐ ‐ a new major product of neutral, aqueous reaction of cytidine with carcinogens. FEBS Letters. 63(1). 85–88. 22 indexed citations
20.
Singer, B. & Jack Wolfsdorf. (1975). Early discharge of infants of low birth weight: a prospective study.. BMJ. 1(5954). 362–364. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yoshiyuki Kuchino Breakdown of academic impact, for papers by Carl W. Porter Breakdown of academic impact, for papers by James E. Thompson Breakdown of academic impact, for papers by Masaru Takeshita Breakdown of academic impact, for papers by Michael A. Sirover Breakdown of academic impact, for papers by Maria C. Shoshan Breakdown of academic impact, for papers by Dianne L. Newton Breakdown of academic impact, for papers by Albert H. Gennip Breakdown of academic impact, for papers by Hans Jörnvall Breakdown of academic impact, for papers by Paul W. Doetsch
Rankless by CCL
2026